Therefore, targeting mTOR and Akt is crucial for lung cancer therapy, and compounds that promote apoptosis and autophagy by inhibiting the PI3 K/Akt/mTOR pathway show potential as promising therapeutic agents20. Here, AKT1 is linked to lung carcinoma.